Safe Orthopaedics Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	5.04	5.81	5.86	4.55	3.66
Revenue Growth (YoY)	-13.24%	-0.87%	28.70%	24.49%	-22.15%
Cost of Revenue	2.48	1.59	2.2	1.98	2.26
Gross Profit	2.57	4.22	3.66	2.57	1.4
Selling, General & Admin	7.8	7.66	8.87	9.27	7.52
Other Operating Expenses	-3.79	-0.13	-0.16	0.02	-0.03
Operating Expenses	5.01	10.41	9.62	10.16	8.07
Operating Income	-2.45	-6.19	-5.96	-7.58	-6.67
Interest Expense	-2,122	-0.22	-0.42	-0.64	-0.86
Interest & Investment Income	259.64	-	0.21	-	-
Currency Exchange Gain (Loss)	-	0.36	-0.64	1.51	-0.78
Other Non Operating Income (Expenses)	0	-263.48	-0.15	-0	0
EBT Excluding Unusual Items	-1,864	-269.52	-6.97	-6.71	-8.31
Impairment of Goodwill	-	-1.79	-	-	-
Asset Writedown	0.2	-	-	-	-
Pretax Income	-1,864	-271.32	-6.97	-6.71	-8.31
Income Tax Expense	65.21	-65.87	-0	-	-
Net Income	-1,929	-205.44	-6.97	-6.71	-8.31
Net Income to Common	-1,929	-205.44	-6.97	-6.71	-8.31
Shares Outstanding (Basic)	2,081	2,081	-	-	-
Shares Outstanding (Diluted)	2,081	2,081	-	-	-
EPS (Basic)	-0.93	-0.10	-	-	-
EPS (Diluted)	-0.93	-0.10	-	-	-
Free Cash Flow	-3.36	64.69	-6.33	-8.22	-6.53
Free Cash Flow Per Share	-0.00	0.03	-	-	-
Gross Margin	50.88%	72.70%	62.52%	56.52%	38.25%
Operating Margin	-48.54%	-106.45%	-101.69%	-166.47%	-182.26%
Profit Margin	-38272.62%	-3536.04%	-118.84%	-147.32%	-227.06%
Free Cash Flow Margin	-66.65%	1113.37%	-107.95%	-180.41%	-178.59%
EBITDA	-2	-3.66	-5	-6.72	-6.1
EBITDA Margin	-39.57%	-62.93%	-85.33%	-147.45%	-166.73%
D&A For EBITDA	0.45	2.53	0.96	0.87	0.57
EBIT	-2.45	-6.19	-5.96	-7.58	-6.67
EBIT Margin	-48.54%	-106.45%	-101.69%	-166.47%	-182.26%
Advertising Expenses	0.02	0.04	0.11	0.07	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.